ACCESS Newswire
19 Jan 2023, 23:13 GMT+10
NEW YORK, NY / ACCESSWIRE / January 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Karyopharm Therapeutics Inc. ('Karyopharm' or the 'Company') (NASDAQ:KPTI). Investors who purchased Karyopharm securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/kpti.
The investigation concerns whether Karyopharm has violated federal securities laws.
On February 8, 2022, Karyopharm reported 'successful'-though ultimately disappointing-results from its Phase 3 SIENDO Study of Xpovio for the treatment of endometrial cancer. Specifically, the treatment reduced patients' risk of disease progression or death by 30%, just barely enough to be considered statistically significant, and median progression-free survival was just 5.7 months compared to 3.8 months among patients randomized to receive a placebo. On this news, Karyopharm's stock price fell $2.05 per share, or 20.02%, to close at $8.19 per share on February 8, 2022.
Then, on March 1, 2022, Karyopharm reported negative feedback from the U.S. Food and Drug Administration ('FDA') on its supplemental NDA for Xpovio based on the Phase 3 SIENDO Study results for endometrial cancer. Specifically, the FDA found that the current results would not support NDA approval as Karyopharm and the FDA participants had differing views on the study's significance and overall clinical benefit for the whole population. On this news, Karyopharm's stock price fell $4.13 per share, or 39.75%, to close at $6.26 per share on March 2, 2022.
If you are aware of any facts relating to this investigation or purchasedKaryopharm shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/kpti. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC
Get a daily dose of Maryland Leader news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Maryland Leader.
More InformationEVERGLADES, Florida: Over the weekend, a diverse coalition of environmental activists, Native American leaders, and residents gathered...
BEIJING, China: China's national soccer team may struggle to stir excitement, but its humanoid robots are drawing cheers — and not...
]LONDON, U.K.: A World Health Organization (WHO) expert group investigating the origins of the COVID-19 pandemic released its final...
DOVER, Delaware: California Governor Gavin Newsom has taken legal aim at Fox News, accusing the network of deliberately distorting...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
TORONTO, Canada: Harvard University and the University of Toronto have created a backup plan to ensure Harvard graduate students continue...
NEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...
TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
Vancouver, Canada: A high-stakes legal showdown is brewing in the world of athleisure. Lululemon, the Canadian brand known for its...
LONDON, U.K.: British oil giant Shell has denied reports that it is in talks to acquire rival oil company BP. The Wall Street Journal...
NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...
WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...